Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type II Diabetic Patients With Nephropathy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT01743014
What this trial is testing

Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy

Who this might be right for
Diabetes Type 2Diabetic NephropathyVascular Disease
AHEPA University Hospital 60
Testing effectiveness (Phase 2)Study completedNCT01200394
What this trial is testing

A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy

Who this might be right for
Diabetic Nephropathies
Pfizer 256
Large-scale testing (Phase 3)Study completedNCT03436693
What this trial is testing

Efficacy and Safety of Canagliflozin (TA-7284) in Patients With Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
Tanabe Pharma Corporation 308
Not applicableStudy completedNCT02704884
What this trial is testing

Microbial Soy Milk Consumption, Inflammation and Renal Function Among Type 2 Diabetic Patients With Nephropathy

Who this might be right for
Type II Diabetic Patients With Nephropathy
Isfahan University of Medical Sciences 48
Large-scale testing (Phase 3)Ended earlyNCT00108485
What this trial is testing

Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy

Who this might be right for
Diabetes Mellitus, Type 2Kidney Failure, ChronicHyperlipidemia
University of Miami 9
Not applicableStudy completedNCT00237952
What this trial is testing

Environmental Exposure to Lead and Progressive Renal Insufficiency in Type II Diabetic Nephropathy

Who this might be right for
Diabetic NephropathiesDiabetes Mellitus, Type II
Chang Gung Memorial Hospital
Not applicableStudy completedNCT02864914
What this trial is testing

Post-authorisation Safety Study in Patients With Type 2 Diabetes to Assess the Risk of Liver Injury, Kidney Injury, Urinary Tract and Genital Infections, and Diabetic Ketoacidosis in Patients Treated With Empagliflozin, Compared to DPP-4 Inhibitors

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 333,580
Not applicableUnknownNCT02035891
What this trial is testing

Low-dose Colchicine in Patients With Type 2 Diabetes Mellitus and Microalbuminuria

Who this might be right for
Diabetic Nephropathy
Chongqing Medical University 160
Not applicableStudy completedNCT00484068
What this trial is testing

Chicken-Diet vs. Enalapril to Reduce Albuminuria

Who this might be right for
MicroalbuminuriaDiabetic Nephropathy
Hospital de Clinicas de Porto Alegre 28
Not applicableNot Yet RecruitingNCT07833228
What this trial is testing

Randomized Double-Blind Trial of Chrocare CDSS for Integrated Management of Type 2 Diabetes

Who this might be right for
Type 2 Diabetes (T2DM)Diabetic NephropathiesDiabetic Retinopathy (DR)
Shanghai Jiao Tong University School of Medicine 1,200
Testing effectiveness (Phase 2)Study completedNCT01487109
What this trial is testing

Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Disease
Concert Pharmaceuticals 170
Large-scale testing (Phase 3)WithdrawnNCT03105219
What this trial is testing

IvaBradinE to Treat MicroalbumiNuria in Patients With Type 2 Diabetes and Coronary Heart Disease

Who this might be right for
Diabetic Kidney Disease
Nanjing First Hospital, Nanjing Medical University
Not applicableUnknownNCT03284996
What this trial is testing

Doppler Ultrasound in Early Detection of Diabetic Nephropathy Type 2 Diabetes Mellitus.

Who this might be right for
Diabetic Nephropathies
Assiut University 80
Large-scale testing (Phase 3)Study completedNCT01875341
What this trial is testing

Role of Sleep Apnea and Sympathetic Activity in Resistant Hypertensive Patients.

Who this might be right for
Type 2 DiabetesDiabetic NephropathyHypertension+1 more
Ottawa Hospital Research Institute 16
Testing effectiveness (Phase 2)Ended earlyNCT04983979
What this trial is testing

The ORTIZ Study: Optimising RASi Therapy With SZC

Who this might be right for
CKDDiabetes Mellitus, Type 2Hyperkalemia
Barts & The London NHS Trust 18
Not applicableActive Not RecruitingNCT05198284
What this trial is testing

Prospective Decision Impact Clinical Utility Trial of KidneyIntelX

Who this might be right for
Diabetic Kidney DiseaseChronic Kidney DiseasesChronic Kidney Disease Stage 1+2 more
Renalytix AI, Inc. 2,000
Early research (Phase 1)Ended earlyNCT03840343
What this trial is testing

Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney DiseaseDiabetic NephropathiesDiabetes Mellitus, Type 2+5 more
Mayo Clinic 2
Post-approval studies (Phase 4)Looking for participantsNCT07026539
What this trial is testing

Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes.

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Chronic Kidney Disease Due to Type 2 Diabetes MellitusCardiovascular Diseases
University of Aarhus 80
Testing effectiveness (Phase 2)Study completedNCT03217591
What this trial is testing

Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria

Who this might be right for
Type 2 Diabetes Mellitus With Diabetic Nephropathy
Akebia Therapeutics 156
Large-scale testing (Phase 3)Ended earlyNCT01351675
What this trial is testing

Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes

Who this might be right for
Renal Insufficiency, ChronicDiabetes Mellitus, Type 2
Biogen 2,185
Next Page